Dr. Qin Ning is a Professor in Hepatology and Clinical Immunology. She is the chair of the institute &Department of Infectious Diseases in Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.
Dr. Ning is the Vice President, Chinese Society of Infectious Disease CMA; the Regional Council Member, International Association for the Study of Liver (IASL); Member for APASL ACLF Study Group and International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) Global Hepatitis Summit (GHS); Executive Committee Member for Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP)
Dr. Ning has published over 363 original papers internationally, including BMJ-British Medical Journal, J Clin Invest, J of Hepatology, J Biol Chem, J Immunol, Human Gene Therapy, Hepatology International, Liver International, Frontiers in Immunology,etc. These works have been cited more than 5706 times .
She also served as editors or reviewers for J Hepatology, Lance Gastroentology and Hepatology, Hepatology International, Human Gene Therapy et al.
Dr. Ning’s clinical care activities include hepatology, clinical immunology, and infectious disease, with focus on viral hepatitis, and recently emerging SARS-CoV-2 infected COVID-19.
讲座视频:0
论文摘要:11
3467
0
0
日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2024-09-20 | 17:20-17:40 | 平行会场一(上海厅) |
专题报告 |
主持 | |
2024-09-21 | 11:20-11:40 | 主会场(北京厅) |
主旨报告 |
讲者 | 协同创新助力感染病学科全面发展 |
2024-09-21 | 15:30-15:50 | 平行会场五(香港厅) |
主题报告 |
讲者 | 重大传染病智慧医疗监测与决策体系探索 |
2024-09-21 | 16:50-17:10 | 平行会场四(澳门厅) |
专题报告 |
主持 | |
2024-09-21 | 16:50-17:10 | 平行会场一(上海厅) |
专题报告 |
主持 | |
2024-09-22 | 08:40-09:00 | 平行会场二(武汉厅) |
主题报告 |
讲者 | Consensus from APASL: ESLD Complicated by Infection |
2024-09-22 | 11:00-11:20 | 平行会场二(武汉厅) |
专题报告 |
主持 |